section name header

Y-Site Injection Compatibility (1:1 Mixture)

Oritavancin diphosphate

(Mfr: TAR)(Conc: 0.8 and 1.2 mg/mLa)

C

Metronidazole

(Mfr: HOS)(Conc: 5 mg/mLb)

Remarks:

Visually compatible for 4 hr at 20 to 24°C

Ref:

2928